Critical evaluation of disease stabilization as a measure of activity of systemic therapy: lessons from trials with arms in which patients do not receive active treatment

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Clinical Trials as Topic*
• Confounding Factors, Epidemiologic
• Disease Progression
• Disease-Free Survival
• Humans
• Neoplasms / drug therapy
• Randomized Controlled Trials as Topic
• Research Design*
• Treatment Outcome*